ScholarLens Back to search
2002•He'nan zhongliuxue zazhiRequires access

The Clinical Response Analysis of Advanced Non-small Cell Lung Cancer with NP Chemotherapy Regimen

Haibo Zhao

Open publisher page 0 citations

Abstract

Objective To evaluate the therapeutic effect of NP combined regimen on advanced non-small cell lung cancer(NSCLC).Methods 27 cases of advanced NSCLC patients received chemotherapy with NVB and PDD.Results overall response rate was 44% (12/27),being 52 9%(9/17) and 30% (3/10) for primary and secondary treatment cases respectively.The effective rate of adenocarcinoma was 33.3% and that of squamous carcinoma was 50%.The main toxic side reactions include arrest of bone marrow and phlebitis.Conclusion It was thought that the combined chemotherapy with NVB and PDD gave just as good effect for advanced lung cancer.

About this research paper

What this paper is about

Objective To evaluate the therapeutic effect of NP combined regimen on advanced non-small cell lung cancer(NSCLC).Methods 27 cases of advanced NSCLC patients received chemotherapy with NVB and PDD.Results overall response rate was 44% (12/27),being 52 9%(9/17) and 30% (3/10) for primary and secondary treatment cases respectively.The effective rate of adenocarcinoma was 33.3% and that of squamous carcinoma was 50%.The main toxic side reactions include arrest of bone marrow and phlebitis.Conclusion It was thought that the combined chemotherapy with NVB and PDD gave just as good effect for advanced lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the therapeutic effect of NP combined regimen on advanced non-small cell lung cancer(NSCLC).Methods 27 cases of advanced NSCLC patients received chemotherapy with NVB and PDD.Results overall response rate was 44% (12/27),being 52 9%(9/17) and 30% (3/10) for primary and secondary treatment cases respectively.The effective rate of adenocarcinoma was 33.3% and that of squamous carcinoma was 50%.The main toxic side reactions include arrest of bone marrow and phlebitis.Conclusion It was thought that the combined chemotherapy with NVB and PDD gave just as good effect for advanced lung cancer.

Key concepts: Medicine, Regimen, Chemotherapy, Lung cancer, Adenocarcinoma, Oncology, Internal medicine, Bone marrow suppression

Back to paper searchBrowse research topicsOriginal source
The Clinical Response Analysis of Advanced Non-small Cell Lung Cancer with NP Chemotherapy Regimen — Research Paper | ScholarLens